Pallas Capital Advisors LLC Ishares Tr Genomics Immunology Transaction History

Pallas Capital Advisors LLC

  • $2.31 Billion
  • Q1 2024

A detailed history of Pallas Capital Advisors LLC transactions in Ishares Tr Genomics Immunology stock. As of the latest transaction made, Pallas Capital Advisors LLC holds 8,316 shares of IDNA stock, worth $190,103. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,316
Previous 20,519 59.47%
Holding current value
$190,103
Previous $472,000 57.63%
% of portfolio
0.01%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024
SELL
$22.28 - $25.2 $271,882 - $307,515
-12,203 Reduced 59.47%
8,316 $200,000
Q4 2023

Jan 22, 2024
SELL
$17.37 - $23.3 $168,992 - $226,685
-9,729 Reduced 32.16%
20,519 $472,000
Q3 2023

Nov 01, 2023
BUY
$20.35 - $24.44 $252,482 - $303,227
12,407 Added 69.54%
30,248 $615,000
Q2 2023

Jul 26, 2023
BUY
$23.05 - $25.1 $411,235 - $447,809
17,841 New
17,841 $416,000

Others Institutions Holding IDNA

# of Institutions
66
Shares Held
1.84M
Call Options Held
0
Put Options Held
0
View Full List

About ISHARES TR GENOMICS IMMUNOLOGY

IDNA Quotes by TradingView
  • Ticker IDNA
  • Sector ETFs
  • Industry ETFs
More about IDNA
Track This Portfolio

Track Pallas Capital Advisors LLC Portfolio

Follow Pallas Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pallas Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pallas Capital Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email